Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vielight has developed patented home-use photobiomodulation devices that deliver non-invasive light therapy to the brain or intranasally. Their technology has demonstrated efficacy in pilot and clinical trials across several conditions including Alzheimer’s disease, traumatic brain injury, depression, PTSD, COVID‑19 recovery, cognitive performance enhancement, sleep improvement, mood elevation and more. The company collaborates with leading academic institutions globally. Clinical results show improved memory/focus/cognition with a strong safety profile; pivotal studies are ongoing for dementia-related disorders and viral recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vielight.